Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The...

6

Transcript of Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The...

Page 1: Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The serogroup A vac- cine has been shown to have a clinical efficacy of 85%-95% and to be of
Page 2: Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The serogroup A vac- cine has been shown to have a clinical efficacy of 85%-95% and to be of
Page 3: Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The serogroup A vac- cine has been shown to have a clinical efficacy of 85%-95% and to be of
Page 4: Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The serogroup A vac- cine has been shown to have a clinical efficacy of 85%-95% and to be of
Page 5: Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The serogroup A vac- cine has been shown to have a clinical efficacy of 85%-95% and to be of
Page 6: Committee (ACIP) of the U.S. Public Health Service Meningococcal Vaccines months (4,5). The serogroup A vac- cine has been shown to have a clinical efficacy of 85%-95% and to be of